EGF and non-small cell lung carcinoma: In a phase III clinical study, it was found that, at a cutoff value of 870 pg/mL, the survival rate of NSCLC patients with high EGF levels was significantly lower than that of patients with low EGF levels (HR, 0.38; 95% CI, 0.20-0.70; P=0.002).